Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/systems-biology-in-biotech-pharma-introduction-discovery-and-9gP9m2EbqW
References (2)
-
A. Prokop (1995)
Challenges in commercial biotechnology. Part I. Product, process, and market discovery.Advances in applied microbiology, 40
-
A. Prokop (1995)
Challenges in commercial biotechnology. Part II. Product, process, and market development.Advances in applied microbiology, 40
- Publisher
- Springer Netherlands
- Copyright
- © The Author(s) 2012
- ISBN
- 978-94-007-2848-6
- Pages
- 1 –10
- DOI
- 10.1007/978-94-007-2849-3_1
- Publisher site
- See Chapter on Publisher Site
Abstract
[In the face of the challenges associated with expiring drug patents, the rising cost of R&D, and payer pressure on pricing, most major pharmaceutical companies are seeking ways to enhance productivity, reduce costs and augment their late-stage pipelines. Recent technological applications have witnessed the development of data-rich, genome-scale functional screens, large collections of reagents and protein microarrays, and the addition of databases and algorithms for data mining. Systems biology takes advantage of these technological breakthroughs to represent a combination of reductionist and holistic approaches to the relationships among the elements of a system.]
Published: Jan 4, 2012
Keywords: System Biology; Emergent Property; Protein Microarrays; System Biology Markup Language; Project Portfolio